Hepion Pharmaceuticals (HEPA) Ownership - Who owns Hepion Pharmaceuticals?

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of drug therapy for the treatment of chronic liver diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

BridgeBio Pharma (BBIO) vs ProMIS Neurosciences (PMN): Weighing Commercial Momentum Against Clinical Promise

TNYA

Tenaya Therapeutics (TNYA): Analyst Targets Suggest a Potential +900% Upside

AUTL

Autolus (AUTL) vs Lexeo (LXEO): Commercial Traction Meets Pre-Revenue Gene Therapy Potential

CVM

CVM and NRXS: Weighing a Pre-Revenue Biotech Against a Scaling Med-Tech Player

ENGN

enGene Therapeutics (ENGN): Analyst Target of $3.30 Implies +113% Upside

View all blogs related to
#Biotechnology

Interesting Articles

What is the Russell 1000?

Unlock the Power of Daily Trade Signals: A Step-by-Step Guide

What is PublicSq and How Did It Revolutionize E-commerce?

Which Small-Cap Stocks Are Topping the Charts in June 2023?

Tickeron Launches Price Action Trading Bots for High-Liquidity Stocks

View all articles

A.I. Advisor

published General Information

General Information

a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease

Industry Biotechnology